ICON Plc

ICON Plc ICON is a global provider of outsourced clinical research development services to the pharmaceutical, biotechnology, and medical device industries.

We help our clients accelerate the development of life-saving drugs that improve patients' quality of life.

Strong patient interest in psychedelic studies is a double edged sword. It can drive engagement but also introduce bias,...
26/05/2026

Strong patient interest in psychedelic studies is a double edged sword. It can drive engagement but also introduce bias, screen failures, and ex*****on risk if not managed carefully. We have pulled together key considerations to help sponsors plan with more confidence. https://ow.ly/432450YXWJ0

Biotech teams face unique pressures, from rapid decision‑making to scaling programmes without losing momentum.Meet the I...
26/05/2026

Biotech teams face unique pressures, from rapid decision‑making to scaling programmes without losing momentum.

Meet the ICON Biotech team at , booth #35093 to learn how our biotech‑dedicated specialists combine flexibility, collaboration and global CRO scale to turn innovation into impact from early development through delivery. https://ow.ly/VoGm50YKP2B

ICON Biotech will be attending this 9 –10 June in London.Visit us at booth #42 to learn how ICON is advancing clinica...
26/05/2026

ICON Biotech will be attending this 9 –10 June in London.

Visit us at booth #42 to learn how ICON is advancing clinical trial solutions with industry-leading expertise and innovation.

From streamlining operations to navigating complex regulatory landscapes, we’re here to support the full journey of clinical development. 13th Annual Outsourcing in Clinical Trials UK & Ireland 2026 - Arena International. https://ow.ly/Goqa50YBeli

First in human development of oligonucleotide drugs requires careful safety evaluation as molecular complexity increases...
25/05/2026

First in human development of oligonucleotide drugs requires careful safety evaluation as molecular complexity increases.

In this webinar, ICON specialists discuss best practices for FIH ON study design and risk mitigation, sharing practical insights into PK/PD, toxicity, dose escalation, immunogenicity, and QT assessment.

Register now: https://ow.ly/ylVo50YNl9r

ICON is proud to be recognised by IMAPAC at the Asia‑Pacific Biopharma Excellence Awards 2026 for excellence in Site Inn...
25/05/2026

ICON is proud to be recognised by IMAPAC at the Asia‑Pacific Biopharma Excellence Awards 2026 for excellence in Site Innovation.

Each milestone like this strengthens our focus on advancing clinical research to support patients waiting for new and better therapies.

Learn more here: https://ow.ly/PnkV50YKPu2

Psychedelic therapies are gaining momentum—but come with very different operational realities than traditional CNS studi...
22/05/2026

Psychedelic therapies are gaining momentum—but come with very different operational realities than traditional CNS studies. From enrolment to regulation, getting the design right early is critical. Here’s what sponsors should consider: https://ow.ly/aGLv50YXWFt

New regulatory guidance from the EMA and FDA is transforming the biosimilars landscape.With the potential to reduce deve...
22/05/2026

New regulatory guidance from the EMA and FDA is transforming the biosimilars landscape.

With the potential to reduce development costs and timelines, these changes open new opportunities — while also increasing competition and complexity for developers. Discover what this means for your biosimilar strategy: https://ow.ly/PzVP50YYSll

At ICON, we are applying artificial intelligence to improve how trials are designed, executed and optimised, from smarte...
22/05/2026

At ICON, we are applying artificial intelligence to improve how trials are designed, executed and optimised, from smarter feasibility to more proactive study management. Visit us at DIA Philadelphia, 14–18 June, Booth #1426 to explore how AI is driving more informed decisions and more efficient delivery. https://ow.ly/a7co50Z29q3

Delivering psychedelic therapies demands more than innovation. Sites often need additional infrastructure. Regulatory ex...
21/05/2026

Delivering psychedelic therapies demands more than innovation. Sites often need additional infrastructure. Regulatory expectations can vary widely by country. Controlled substance handling adds another layer of risk.

Read the case study to discover how ICON delivered full service support for a global psychedelic programme across 150+ sites, coordinating multiple vendors and enabling enrolment of more than 700 patients under highly specialised conditions.
https://ow.ly/KeZq50YXWyS

ICON will be at CYTO 2026 in West Palm Beach, Florida (6–10 June). Join us at booth #715 to connect with our flow cytom...
21/05/2026

ICON will be at CYTO 2026 in West Palm Beach, Florida (6–10 June). Join us at booth #715 to connect with our flow cytometry team and learn how we support innovative trial design through a coordinated global network. If you’re navigating complex studies or planning your next approach, we’d welcome the conversation. https://ow.ly/1ciY50YQTS1

Behind every successful oncology programme is experience you can trust.With 11,000+ oncology and haematology specialists...
21/05/2026

Behind every successful oncology programme is experience you can trust.

With 11,000+ oncology and haematology specialists, ICON has supported 840+ oncology studies in the past five years and contributed to 47 FDA and EMA approved therapies.

Visit us at ASCO 2026, booth #35093 to connect with our oncology specialists and explore scalable, predictable trial delivery. https://ow.ly/cbUT50YKOYH

Address

South County Business Park, Leopardstown
Dublin
18

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+35312912000

Website

Alerts

Be the first to know and let us send you an email when ICON Plc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ICON Plc:

Shortcuts

Featured

Share

Category